Literature DB >> 31318031

Rotavirus Vaccination Coverage During a Rotavirus Outbreak Resulting in a Fatality at a Subacute Care Facility.

Rachel M Burke1,2, Jacqueline E Tate1, George S Han3, Rebecca Quenelle3, Rashi Gautam4, Debra A Wadford5, Michael D Bowen1, Umesh D Parashar1.   

Abstract

BACKGROUND: The introduction of rotavirus vaccine in the United States has reduced rotavirus disease burden, but outbreaks still occur. Complete-series rotavirus vaccination coverage is <75% in the United States, and it might be lower among vulnerable populations. We describe here the clinical characteristics and vaccination status of children during a rotavirus outbreak in a pediatric subacute care facility in 2017.
METHODS: Clinical history, signs and symptoms, and vaccination history were abstracted for the 26 patients residing in the facility during the time of the outbreak. A case-patient was defined as one who experienced 3 or more loose stools in a period of 24 hours with onset between April 17 and May 17, 2017. Stool samples from 14 resident patients were tested for rotavirus with reverse-transcription polymerase chain reaction.
RESULTS: The median patient age at the facility was 2.9 years. Of the 26 resident patients, 22 (85%) met the case definition. One child died. Stool samples from 11 case-patients were positive according to reverse-transcription polymerase chain reaction for rotavirus. Fifteen case-patients were unvaccinated against rotavirus; 3 were partially vaccinated, and 2 were fully vaccinated. Vaccination status could not be completely determined in 2 cases.
CONCLUSIONS: An outbreak of rotavirus affected nearly all resident patients of a subacute care facility and caused 1 death. Because of recommendations against giving rotavirus vaccine in an intensive care setting, infants who require a prolonged intensive care stay might age out of rotavirus vaccine eligibility (the first dose must be given before 15 weeks of age according to Advisory Committee on Immunization Practices recommendations). The result is a vulnerable population of unvaccinated infants who might later congregate in another care setting. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society 2019.

Entities:  

Keywords:  immunization; pediatric gastroenteritis; rotavirus; vaccines

Mesh:

Substances:

Year:  2020        PMID: 31318031      PMCID: PMC6980350          DOI: 10.1093/jpids/piz015

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  22 in total

1.  Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program.

Authors:  Jacqueline E Tate; Lone Simonsen; Cecile Viboud; Claudia Steiner; Manish M Patel; Aaron T Curns; Umesh D Parashar
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

2.  Clinical manifestations of rotavirus infection in the neonatal intensive care unit.

Authors:  Renu Sharma; Mark L Hudak; Bangalore R Premachandra; Gary Stevens; Carmela B Monteiro; James A Bradshaw; Andrew M Kaunitz; Robert A Hollister
Journal:  Pediatr Infect Dis J       Date:  2002-12       Impact factor: 2.129

3.  Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units.

Authors:  Samuel Thrall; Margaret K Doll; Charles Nhan; Milagros Gonzales; Thérèse Perreault; Philippe Lamer; Caroline Quach
Journal:  Vaccine       Date:  2015-08-18       Impact factor: 3.641

4.  Slow uptake of rotavirus vaccination in UK neonatal units.

Authors:  Siobhan Jaques; Bikash Bhojnagarwala; Nigel Kennea; Donovan Duffy
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2014-03-04       Impact factor: 5.747

5.  Rotavirus Vaccination Can Be Performed Without Viral Dissemination in the Neonatal Intensive Care Unit.

Authors:  Hiroyuki Hiramatsu; Ryota Suzuki; Arisa Nagatani; Hiroko Boda; Masafumi Miyata; Fumihiko Hattori; Hiroki Miura; Ken Sugata; Shigeki Yamada; Satoshi Komoto; Koki Taniguchi; Masaru Ihira; Naoko Nishimura; Takao Ozaki; Tetsushi Yoshikawa
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

6.  Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

7.  Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination.

Authors:  Patricia Bruijning-Verhagen; Marie-Josée J Mangen; Mariet Felderhof; Nico G Hartwig; Marlies van Houten; Léon Winkel; Wouter J de Waal; Marc J M Bonten
Journal:  BMC Med       Date:  2013-04-26       Impact factor: 8.775

8.  Sustained decrease in laboratory detection of rotavirus after implementation of routine vaccination—United States, 2000-2014.

Authors:  Negar Aliabadi; Jacqueline E Tate; Amber K Haynes; Umesh D Parashar
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-04-10       Impact factor: 17.586

9.  Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.

Authors:  Daniel C Payne; Rangaraj Selvarangan; Parvin H Azimi; Julie A Boom; Janet A Englund; Mary Allen Staat; Natasha B Halasa; Geoffrey A Weinberg; Peter G Szilagyi; James Chappell; Monica McNeal; Eileen J Klein; Leila C Sahni; Samantha H Johnston; Christopher J Harrison; Carol J Baker; David I Bernstein; Mary E Moffatt; Jacqueline E Tate; Slavica Mijatovic-Rustempasic; Mathew D Esona; Mary E Wikswo; Aaron T Curns; Iddrisu Sulemana; Michael D Bowen; Jon R Gentsch; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2015-10-08       Impact factor: 9.079

10.  Three Rotavirus Outbreaks in the Postvaccine Era - California, 2017.

Authors:  Rachel M Burke; Jacqueline E Tate; Nora Barin; Carly Bock; Michael D Bowen; David Chang; Rashi Gautam; George Han; John Holguin; Thalia Huynh; Chao-Yang Pan; Rebecca Quenelle; Catherine Sallenave; Cindy Torres; Debra Wadford; Umesh Parashar
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-04-27       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.